MedTrace Logo

Comprehensive Outcomes Monitoring for Peri- and Postnatal Invasive Group B Strep Sequelae (COMPPASS) Registry

NCT06896526 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2025-03-26

No results posted yet for this study

Summary

The goal of this registry is to collect and store important medical and non-health information on children from 0 to 18 years of age affected by early- (up to 24 hours after birth) and late-onset (up to 90 days after birth) invasive Group B Streptococcus (iGBS) and their families. Data collected from families of children affected by perinatal iGBS will support further research to understand the short- and long-term impact of iGBS disease on affected children and its impact on their families. Participants will be invited to complete obstetric and pregnancy-related questionnaires as well as validated neurodevelopmental surveys at various timepoints throughout their participation in the registry.

Conditions

  • Invasive Group B Streptococcus Disease
  • Group B Streptococcus
  • Group B Streptococcal Infection
  • Group B Streptococcus (GBS) Disease
  • Group B Streptococcal Infection, Early-Onset
  • Group B Streptococcal Infection, Late-Onset

Sponsors & Collaborators

  • Precia Group

    lead INDUSTRY

Principal Investigators

  • Donna Russell, MPA · Precia Group

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-01
Primary Completion
2035-03-31
Completion
2035-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06896526 on ClinicalTrials.gov